Durability of SARS-CoV-2–Specific T-Cell Responses at 12 Months PostinfectionZhongyan Lu, Daniel E. Clark, Camille Lake et al.|The Journal of Infectious Diseases|2021Cited by 42
Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease 2019Stephanie A Richard, M. Wayman, Nusrat J Epsi et al.|Open Forum Infectious Diseases|2021Cited by 36
COVID-19 Patient-Reported Symptoms Using FLU-PRO Plus in a Cohort Study: Associations With Infecting Genotype, Vaccine History, and Return to HealthStephanie A Richard, Josh Chenoweth, Nusrat J Epsi et al.|Open Forum Infectious Diseases|2022Cited by 14
Predictive Value of an Age-Based Modification of the National Early Warning System in Hospitalized Patients With COVID-19Ryan C. Maves, Michal Stein, Stephanie A Richard et al.|Open Forum Infectious Diseases|2021Cited by 7